체외진단(IVD) 검사 분야 바이오인포매틱스 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 연평균 6.8%의 성장률(CAGR)로 1,298억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 질병 유병률 증가, 헬스케어 분야에서의 IT 통합, 정부의 이니셔티브와 자금 지원, 개인 맞춤형 의료로의 전환, 의료 서비스 제공업체의 진단에 있어 바이오인포매틱스의 이점에 대한 인식 증가, 유전체 시퀀싱 비용의 감소에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 인공지능(AI)과 머신러닝, 차세대 시퀀싱, 현장진단(POC) 검사, 클라우드 컴퓨팅과 빅데이터, 면역화학 방법론의 혁신 등을 꼽을 수 있습니다.
IVD(체외진단) 검사 시장에서 바이오인포매틱스의 성장은 암의 유병률 증가가 견인할 것으로 예측됩니다. 암은 세포의 비정상적인 증식을 특징으로 하는 질병군을 말하며, 주변 조직을 침범하고 신체의 다른 부위로 전이될 가능성이 있습니다. 생활습관, 환경적 영향, 피폭 위험 등 다양한 요인들이 암 유병률 상승에 기여하고 있습니다. 체외진단용 의약품 테스트의 바이오인포매틱스는 조기 발견을 개선하고, 치료 결정을 안내하며, 환자 결과를 개선할 수 있는 정확하고 개인화된 유전학적 통찰력을 제공함으로써 암 진단에 변화를 가져오고 있습니다. 예를 들어, 2022년 미국 정부 기관인 NACDD(National Association of Chronic Disease Directors)는 미국 성인의 약 40%가 여러 개의 만성질환(MCC)을 앓고 있다고 보고했습니다. 또한, 만성질환을 하나라도 앓고 있으면, 특히 나이가 들면서 추가 질환을 발병할 가능성이 높아진다는 데이터도 있습니다. 결과적으로 암 유병률 증가는 IVD 검사 시장에서 바이오인포매틱스 수요를 촉진하고 있습니다.
이 시장의 주요 기업들은 기술 혁신, 특히 차세대 염기서열 분석(NGS) 기술에 집중하고 있으며, NGS는 전체 유전체 또는 특정 DNA/RNA 영역의 신속한 염기서열 분석을 가능하게 하여 종합적인 유전자 분석을 용이하게 합니다. 예를 들어, 2022년 5월, 일루미나는 CE 마크를 획득한 TruSight Oncology Comprehensive(EU) 검사에 범암 동반진단(CDx) 적응증을 도입했습니다. 이 검사는 신경 영양형 티로신 수용체 키나아제(NTRK) 유전자 융합(NTRK1, NTRK2 또는 NTRK3)을 보유한 고형암 환자 중 바이엘의 비트락비(성분명: 랄로트렉티닙)로 표적치료가 가능한 환자를 선별합니다. Comprehensive(EU) 검사는 차세대 염기서열 분석기를 이용한 종합적인 유전체 프로파일링(CGP)을 통해 하나의 생검 검체에서 여러 종양 유전자와 바이오마커를 분석하여 각 환자 고유의 암 분자 프로파일을 결정합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 체외진단(IVD) 검사 분야 바이오인포매틱스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 성장률 분석
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 실적 : 규모와 성장, 2019-2024
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 체외진단(IVD) 검사 분야 바이오인포매틱스 전체 시장(TAM)
제6장 시장 세분화
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 하드웨어
- 소프트웨어
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 테스트 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 혈액검사
- 조직 기반 검사
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 심혈관 질환
- 만성 질환
- 당뇨병
- 암
- 기타 용도
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 하드웨어 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 애널라이저
- 실험장치
- 데이터 스토리지 디바이스
- 센서 및 검출기
- 워크스테이션 및 데이터 처리 하드웨어
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 소프트웨어 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 바이오인포매틱스 플랫폼
- 데이터 관리 및 통합 소프트웨어
- 분석 및 해석 소프트웨어
- 클라우드 기반 소프트웨어 솔루션
- 진단용 AI 기반 소프트웨어
제7장 지역별/국가별 분석
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 경쟁 구도
- 체외진단(IVD) 검사 분야 바이오인포매틱스 시장 : 기업 개요
- Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
- Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
- Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
- Illumina Inc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- PerkinElmer Inc.
- QIAGEN N.V.
- Kollmorgen Corp
- Bioreference Laboratories Inc.
- AssureRx Health Inc.
- Biodesix Inc.
- Crescendo Bioscience Inc.
- Affymetrix
- Complete Genomics Inc.
- Aperico Technologies Inc.
- One Lambda Inc.
- Datech Oncology
- Life Technologies
- Signal genetics
- CardioDx Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 체외진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 새로운 기회를 제공하는 국가
- 체외진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 새로운 기회를 제공하는 부문
- 체외진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 성장 전략
제36장 부록
LSH
Bioinformatics in in vitro diagnostics (IVD) involves applying computational methods, data analysis, and software tools to interpret biological data from diagnostic tests conducted outside the living organism. This includes using algorithms and statistical models to process large volumes of molecular and clinical data.
In the realm of bioinformatics in IVD testing, hardware encompasses the physical components and devices used in laboratory and computational settings. These tests, which include blood-based and tissue-based assays, find applications in detecting conditions such as cardiovascular diseases, chronic illnesses, diabetes, cancer, among others.
The bioinformatics in IVD testing market research report is one of a series of new reports from The Business Research Company that provides bioinformatics in IVD testing market statistics, including bioinformatics in IVD testing industry global market size, regional shares, competitors with bioinformatics in IVD testing market share, detailed bioinformatics in IVD testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bioinformatics in IVD testing industry. This bioinformatics in IVD testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics in in-vitro diagnostics (IVD) testing market size has grown strongly in recent years. It will grow from $93.02 billion in 2024 to $99.69 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to improved healthcare infrastructure, expansion of biobanks, rising geriatric population, government initiatives and funding, and growth of personalized medicine.
The bioinformatics in in-vitro diagnostics (IVD) testing market size is expected to see strong growth in the next few years. It will grow to $129.89 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising prevalence of diseases, integration of IT in healthcare, government initiatives and funding, the shift towards personalized medicine, enhanced awareness about the benefits of bioinformatics in diagnostics among healthcare providers, and the decreasing cost of genomic sequencing. Major trends in the forecast period include artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing and big data, and innovations in immunochemical techniques.
The rising prevalence of cancer is expected to drive growth in the bioinformatics in IVD (in vitro diagnostics) testing market. Cancer refers to a group of diseases marked by abnormal cell growth, which can invade surrounding tissues and spread to other parts of the body. Various factors, including lifestyle, environmental influences, and exposure risks, contribute to the increasing prevalence of cancer. Bioinformatics in IVD testing is transforming cancer diagnostics by providing precise, personalized genetic insights that improve early detection, guide treatment decisions, and enhance patient outcomes. For instance, in 2022, the National Association of Chronic Disease Directors (NACDD), a U.S.-based government agency, reported that approximately 40% of American adults live with multiple chronic conditions (MCC). The data also shows that having one chronic illness increases the likelihood of developing additional conditions, particularly with age. As a result, the growing prevalence of cancer is fueling demand for bioinformatics in the IVD testing market.
Leading companies in this market are focused on innovation, particularly in next-generation sequencing (NGS) technology. NGS enables rapid sequencing of entire genomes or specific DNA and RNA regions, facilitating comprehensive genetic analysis. For example, in May 2022, Illumina Inc. introduced a pan-cancer companion diagnostic (CDx) indication for its CE-marked TruSight Oncology Comprehensive (EU) test. This test identifies cancer patients with solid tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions (NTRK1, NTRK2, or NTRK3), who may benefit from targeted therapy with Bayer's Vitrakvi (larotrectinib). The TSO Comprehensive (EU) test employs comprehensive genomic profiling (CGP), using next-generation sequencing to analyze multiple tumor genes and biomarkers from a single biopsy specimen, thereby determining each patient's specific cancer molecular profile.
In September 2024, QIAGEN N.V., a Germany-based molecular diagnostics company, partnered with Eli Lilly and Company to develop the first in vitro diagnostic (IVD) test for APOE genotyping, specifically for Alzheimer's disease, utilizing QIAGEN's QIAstat-Dx platform. This collaboration represents a significant advancement in neurodegenerative disease diagnostics, expanding QIAGEN's clinical applications and partnerships in diagnostic development. Eli Lilly and Company, a U.S.-based pharmaceutical firm, specializes in in vitro diagnostics (IVD) testing.
Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioinformatics in in-vitro diagnostics (IVD) testing market consists of revenues earned by entities by providing services such as clinical decision support systems, sequence analysis, and clinical genomics software. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics in in vitro diagnostics (IVD) testing market also includes sales of sequencing tools and diagnostics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioinformatics in in-vitro diagnostics (ivd) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bioinformatics in in-vitro diagnostics (ivd) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics in in-vitro diagnostics (ivd) testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Hardware; Software
- 2) By Type Of Test: Blood Based Tests; Tissue Based Tests
- 3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
- Subsegments:
- 1) By Hardware: Analyzers; Laboratory Equipment; Data Storage Devices; Sensors And Detectors; Workstations And Data Processing Hardware
- 2) By Software: Bioinformatics Platforms; Data Management and Integration Software; Analytics And Interpretation Software; Cloud-Based Software Solutions; AI-Based Software For Diagnostics
- Companies Mentioned: Siemens Healthineers; International Business Machines Corporation; Medtronic Inc.; Parker Hannifin Corp.; Illumina Inc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Characteristics
3. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Trends And Strategies
4. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Growth Analysis And Strategic Analysis Framework
- 5.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Growth Rate Analysis
- 5.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Total Addressable Market (TAM)
6. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Segmentation
- 6.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hardware
- Software
- 6.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Based Tests
- Tissue Based Tests
- 6.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cardiovascular Diseases
- Chronic Diseases
- Diabetes
- Cancer
- Other Applications
- 6.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Analyzers
- Laboratory Equipment
- Data Storage Devices
- Sensors And Detectors
- Workstations And Data Processing Hardware
- 6.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioinformatics Platforms
- Data Management and Integration Software
- Analytics And Interpretation Software
- Cloud-Based Software Solutions
- AI-Based Software For Diagnostics
7. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Regional And Country Analysis
- 7.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 8.1. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 9.1. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 9.2. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 10.1. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 11.1. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 11.2. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 12.1. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 13.1. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 14.1. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 14.2. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 15.1. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 15.2. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 16.1. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 17.1. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 18.1. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 19.1. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 20.1. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 21.1. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 21.2. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 22.1. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 23.1. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 23.2. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 24.1. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 24.2. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 25.1. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 25.2. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 26.1. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 26.2. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 27.1. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 28.1. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 28.2. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
- 29.1. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
- 29.2. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape And Company Profiles
- 30.1. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape
- 30.2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Company Profiles
- 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis
31. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Other Major And Innovative Companies
- 31.1. PerkinElmer Inc.
- 31.2. QIAGEN N.V.
- 31.3. Kollmorgen Corp
- 31.4. Bioreference Laboratories Inc.
- 31.5. AssureRx Health Inc.
- 31.6. Biodesix Inc.
- 31.7. Crescendo Bioscience Inc.
- 31.8. Affymetrix
- 31.9. Complete Genomics Inc.
- 31.10. Aperico Technologies Inc.
- 31.11. One Lambda Inc.
- 31.12. Datech Oncology
- 31.13. Life Technologies
- 31.14. Signal genetics
- 31.15. CardioDx Inc.
32. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
34. Recent Developments In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
35. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market High Potential Countries, Segments and Strategies
- 35.1 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
